Part 1 obgyn notes Sri Lanka
    NOTES for part 1
    /
    Microbiology
    /
    RUBELLA

    RUBELLA

    Owner
    U
    Untitled
    Verification
    Tags

    🔬 MICROBIOLOGY OF RUBELLA (German Measles)

    ✅ 1. Virus Basics

    • Family: Togaviridae
    • Genus: Rubivirus
    • Type: Enveloped, single-stranded, +sense RNA virus
    • Transmission: Respiratory droplets, vertical transmission (transplacental)

    Memory Hook:

    “Toga = wearing a coat → enveloped; Ruby = Rubella = red rash.”

    ✅ 2. Replication & Pathogenesis

    1. Enters via respiratory tract
    2. Replicates in nasopharynx + cervical lymph nodes
    3. Causes viremia → spreads to skin, organs, placenta
    4. Crosses placenta easily, especially during 1st trimester

    Why dangerous in early pregnancy?

    Because rubella is teratogenic → disrupts organogenesis.

    ✅ 3. Clinical Features

    ► In Mother

    • Mild illness: low-grade fever, lymphadenopathy (post-auricular), maculopapular rash
    • Arthralgia + arthritis common

    ► In Fetus – Congenital Rubella Syndrome (CRS)

    Classic Triad:

    1. Sensorineural deafness (most common)
    2. Cataracts
    3. Congenital heart disease – PDA, pulmonary artery stenosis

    Other features:

    • Microcephaly, developmental delay
    • “Blueberry muffin baby” (extramedullary hematopoiesis)
    • Hepatosplenomegaly
    • IUGR
    • Thrombocytopenic purpura

    Memory Hook:

    “Heart, Eyes, Ears”—Rubella attacks where baby communicates with the world.

    ✅ 4. Diagnosis

    ► In Mother

    • Rubella IgM positive = recent infection
    • IgG:
      • Negative → not immune
      • Positive → immune (vaccine or prior infection)
    • PCR from throat swab (rare in routine practice)

    ► In Fetus

    • Ultrasound findings:
      • IUGR
      • Cardiac anomalies
      • Microcephaly
      • Hepatosplenomegaly
      • Intracranial calcifications
      • Hydrocephalus
    • Amniotic fluid PCR for confirmation

    🤰 MANAGEMENT OF PREGNANT MOTHER WITH RUBELLA

    ⭐ The 20% rules you MUST remember to get 80% of exam marks:

    1️⃣ Before Pregnancy:

    • Vaccination (MMR) – live vaccine → contraindicated in pregnancy
    • Women should avoid pregnancy for 1 month after MMR.

    2️⃣ If Pregnant & Non-immune (IgG−)

    • Cannot vaccinate during pregnancy
    • Counsel about exposure risk
    • If exposed → check IgM + IgG immediately and repeat after 1–2 weeks

    3️⃣ If Mother Has Acute Rubella in Pregnancy

    The MOST IMPORTANT: Risk depends on gestational age

    Gestational Age
    Risk of Fetal Infection
    CRS Severity
    Management
    < 12 weeks
    >80%
    Severe CRS
    Offer termination
    12–20 weeks
    25–30%
    Milder CRS possible
    Detailed counseling + serial USG
    > 20 weeks
    <1%
    Rare CRS
    Reassure + routine follow-up

    This table is PURE GOLD for exam marks.

    4️⃣ Investigations During Pregnancy

    1. Maternal Serology – IgM (acute), IgG (immunity)
    2. Repeat serology to confirm seroconversion
    3. Serial anomaly scans every 4 weeks
    4. Fetal echocardiography (look for PDA etc.)
    5. Amniotic fluid PCR if needed

    5️⃣ Fetal Monitoring

    • Growth scans (IUGR common)
    • Neurosonogram
    • Check for calcifications, ventriculomegaly
    • Cardiac defects

    6️⃣ Is There Any Treatment?

    • NO antiviral therapy
    • NO role for immunoglobulin to protect fetus (only gives temporary maternal benefit)
    • Management is counseling + monitoring + delivery planning

    7️⃣ After Delivery

    If baby suspected of CRS:

    • Isolate for 1 year (virus shedding)
    • Confirm with:
      • Infant IgM
      • PCR from urine, throat, blood

    Manage CRS complications:

    • Hearing evaluation
    • Ophthalmology review
    • Congenital heart disease assessment
    • Neurological development follow-up

    🎯 SUPER-HIGH-YIELD SUMMARY (what examiner wants)

    Virus

    • Togavirus, enveloped, ssRNA+

    Danger

    • Teratogenic in 1st trimester → CRS (heart, eyes, ears)

    Diagnosis

    • Mother: IgM (acute), IgG (immunity)
    • Fetus: USG + PCR

    Management by Gestation

    • <12 weeks → high risk → offer termination
    • 12–20 weeks → counsel + serial scans
    • >20 weeks → low risk → reassure

    Prevention

    • MMR before pregnancy, not during

    🧠 ELABORATIVE CLINICAL SCENARIO — RUBELLA IN PREGNANCY (EXAM-PERFECT FLOW)

    📍 Clinical Vignette

    A 26-year-old primigravida, G1P0, at 9 weeks’ gestation presents to the antenatal clinic with:

    • Low-grade fever
    • Mild maculopapular rash starting on face and spreading to trunk
    • Post-auricular and posterior cervical lymphadenopathy
    • Arthralgia of small joints

    She reports that one week earlier, a child at her workplace had a febrile rash illness.

    She is unsure of her vaccination status.

    🦠 Step 1: Think of the Virus (Microbiology → Exam Trigger)

    Based on:

    • Mild maternal illness
    • Lymphadenopathy + rash
    • Pregnancy

    You suspect Rubella (German measles).

    Virology recalled immediately:

    • Family: Togaviridae
    • Genus: Rubivirus
    • Structure:
      • Enveloped
      • Single-stranded positive-sense RNA
    • Transmission:
      • Respiratory droplets
      • Vertical (transplacental)

    👉 Key danger flag: Rubella is teratogenic, especially in early pregnancy.

    🔬 Step 2: Pathogenesis (WHY fetus is at risk)

    You explain to the patient:

    1. Virus enters via respiratory tract
    2. Replicates in nasopharynx & cervical lymph nodes
    3. Causes viremia
    4. Virus disseminates to:
      • Skin
      • Maternal organs
      • Placenta
    5. Crosses placenta easily, especially in 1st trimester
    6. Infects fetal tissues during organogenesis

    👉 This explains why early pregnancy infection causes severe congenital anomalies.

    🧪 Step 3: Immediate Investigations (Mother)

    You order rubella serology:

    • Rubella IgM
    • Rubella IgG

    Results return:

    • IgM: Positive
    • IgG: Negative

    📌 Interpretation:

    • Acute primary rubella infection
    • Mother is non-immune
    • Infection occurred during pregnancy

    ⚠️ Step 4: Gestational Age = EVERYTHING

    You now assess risk based on gestational age.

    She is 9 weeks pregnant.

    Gestation
    Fetal Infection Risk
    CRS Severity
    <12 weeks
    >80%
    Severe CRS

    This immediately places her in the highest-risk category.

    👶 Step 5: Explain Fetal Risks (CRS — Examiner Core)

    You counsel her clearly about Congenital Rubella Syndrome (CRS).

    Classic Triad (must be said aloud):

    1. Sensorineural deafness (most common)
    2. Cataracts
    3. Congenital heart disease
      • PDA
      • Pulmonary artery stenosis

    Other possible features:

    • Microcephaly
    • Developmental delay
    • IUGR
    • Hepatosplenomegaly
    • Thrombocytopenic purpura
    • “Blueberry muffin baby” (extramedullary hematopoiesis)

    You emphasize:

    “Rubella mainly damages heart, eyes, and ears—the organs forming at this stage.”

    🩺 Step 6: Fetal Assessment (Even though risk is high)

    You still follow protocol and arrange:

    Ultrasound assessment

    Looking for:

    • IUGR
    • Microcephaly
    • Cardiac anomalies
    • Hepatosplenomegaly
    • Ventriculomegaly
    • Intracranial calcifications

    Fetal echocardiography

    • To detect PDA or structural heart disease

    Amniotic fluid PCR

    • Offered for confirmation of fetal infection
    • Especially useful if pregnancy is continued

    🚨 Step 7: MANAGEMENT DECISION (THE EXAM GOLD POINT)

    Because she is:

    • <12 weeks
    • With confirmed acute rubella infection
    • With >80% risk of severe CRS

    👉 Management = OFFER TERMINATION OF PREGNANCY

    You clearly state:

    • No treatment can reverse fetal damage
    • Continuing pregnancy carries very high risk of severe disability

    📌 Important exam line:

    • Decision must be non-directive
    • Based on informed counseling

    ❌ Step 8: What You CANNOT Do (Trick Traps)

    You explicitly state:

    • ❌ No antiviral therapy exists
    • ❌ Immunoglobulin does NOT prevent fetal infection
    • ❌ Vaccination is contraindicated in pregnancy (live vaccine)

    (Immunoglobulin may reduce maternal symptoms only, not fetal risk.)

    🔁 Alternative Branch (If Gestation Was Different)

    You briefly explain scenarios (examiner loves this):

    If 12–20 weeks:

    • Fetal infection risk ~25–30%
    • CRS may be milder
    • Management:
      • Detailed counseling
      • Serial anomaly scans
      • Fetal echo
      • Neurosonogram
      • Consider amniotic PCR

    If >20 weeks:

    • Fetal infection risk <1%
    • CRS very rare
    • Reassure
    • Routine antenatal care

    👶 Step 9: If Pregnancy Continues & Baby Is Born

    If CRS is suspected at birth:

    Neonatal diagnosis

    • Infant Rubella IgM
    • PCR from:
      • Urine
      • Throat swab
      • Blood

    Infection control

    • Isolate infant for up to 1 year
      • Virus shedding persists

    Multidisciplinary follow-up

    • Audiology (hearing loss common)
    • Ophthalmology (cataracts)
    • Cardiology (PDA)
    • Neurodevelopmental assessment

    🛡️ Step 10: PREVENTION (End the scenario strong)

    You conclude counseling with prevention:

    • MMR vaccination BEFORE pregnancy
    • Live vaccine → contraindicated during pregnancy
    • Avoid pregnancy for 1 month after MMR

    🏆 FINAL EXAM-READY TAKE-HOME (What Examiner Wants to Hear)

    • Rubella = enveloped ssRNA+ Togavirus
    • Mild maternal illness, severe fetal disease
    • 1st trimester infection = severe CRS
    • Diagnosis: IgM (acute), IgG (immunity)
    • <12 weeks → offer termination
    • No treatment, no fetal protection
    • Prevention = vaccination before pregnancy

    🦠 RUBELLA (GERMAN MEASLES) — COMPLETE MASTER TABLES

    TABLE 1: VIROLOGY & MICROBIOLOGY (EXAM CORE)

    Aspect
    Details
    Virus name
    Rubella virus (German measles)
    Family
    Togaviridae
    Genus
    Rubivirus
    Genome
    Single-stranded RNA, positive sense (+ssRNA)
    Envelope
    Present (enveloped)
    Capsid
    Icosahedral
    Replication site
    Cytoplasm
    Transmission
    Respiratory droplets, vertical (transplacental)
    Incubation period
    ~14–21 days
    Key danger
    Teratogenic, especially 1st trimester
    Memory hook
    Toga = coat → enveloped; Ruby = red rash

    TABLE 2: PATHOGENESIS (MOTHER → FETUS LOGIC)

    Step
    Event
    Exam Significance
    Entry
    Respiratory tract
    Droplet spread
    Primary replication
    Nasopharynx, cervical lymph nodes
    Explains lymphadenopathy
    Viremia
    Virus enters bloodstream
    Systemic spread
    Placental invasion
    Virus infects placenta
    Key fetal risk
    Transplacental spread
    Crosses placenta easily
    Especially 1st trimester
    Fetal damage
    Disrupts organogenesis
    Congenital Rubella Syndrome

    TABLE 3: CLINICAL FEATURES — MOTHER vs FETUS

    Domain
    Features
    Maternal illness
    Mild fever, maculopapular rash (face → trunk), post-auricular & posterior cervical lymphadenopathy, arthralgia/arthritis
    Severity in mother
    Usually mild, self-limiting
    Fetal syndrome
    Congenital Rubella Syndrome (CRS)
    CRS classic triad
    Sensorineural deafness, cataracts, congenital heart disease (PDA, pulmonary artery stenosis)
    Other CRS features
    Microcephaly, developmental delay, IUGR, hepatosplenomegaly, thrombocytopenic purpura
    Special sign
    Blueberry muffin baby (extramedullary hematopoiesis)

    TABLE 4: DIAGNOSIS — MOTHER & FETUS

    A. Maternal Diagnosis

    Test
    Interpretation
    Rubella IgM
    Positive = recent/acute infection
    Rubella IgG
    Positive = immune; Negative = non-immune
    Paired serology
    Rising IgG = seroconversion
    PCR (throat)
    Rarely used in routine practice

    B. Fetal Diagnosis

    Modality
    Findings
    Ultrasound
    IUGR, microcephaly, hepatosplenomegaly, ventriculomegaly, intracranial calcifications
    Fetal echocardiography
    PDA, pulmonary artery stenosis
    Amniotic fluid PCR
    Confirms fetal infection

    TABLE 5: GESTATIONAL AGE vs RISK vs MANAGEMENT (EXAM GOLD)

    Gestational Age
    Risk of Fetal Infection
    CRS Severity
    Management
    < 12 weeks
    >80%
    Severe CRS
    Offer termination
    12–20 weeks
    25–30%
    Milder CRS possible
    Detailed counseling + serial scans
    > 20 weeks
    <1%
    Rare CRS
    Reassure, routine ANC

    TABLE 6: MANAGEMENT OF RUBELLA IN PREGNANCY (STEPWISE)

    Situation
    Management
    Pre-pregnancy
    MMR vaccination
    Vaccine type
    Live attenuated
    During pregnancy
    Vaccination contraindicated
    Non-immune pregnant woman
    Counsel + avoid exposure
    Exposure in pregnancy
    Check IgM & IgG immediately, repeat in 1–2 weeks
    Acute infection confirmed
    Manage based on gestational age
    Antiviral therapy
    None available
    Immunoglobulin
    ❌ Does NOT protect fetus
    Core approach
    Counseling + monitoring

    TABLE 7: FETAL MONITORING DURING PREGNANCY

    Investigation
    Purpose
    Serial growth scans
    Detect IUGR
    Targeted anomaly scan
    Structural defects
    Neurosonogram
    CNS abnormalities
    Fetal echocardiography
    Cardiac defects
    Amniotic fluid PCR
    Confirm infection

    TABLE 8: NEONATAL MANAGEMENT (CRS SUSPECTED)

    Aspect
    Details
    Diagnosis
    Infant IgM, PCR (urine, throat, blood)
    Infection control
    Isolate infant up to 1 year
    Reason
    Prolonged viral shedding
    Hearing assessment
    Mandatory
    Ophthalmology
    Cataracts
    Cardiology
    PDA evaluation
    Neurodevelopment
    Long-term follow-up

    TABLE 9: WHAT YOU MUST NOT DO (EXAM TRAPS)

    Intervention
    Status
    Antivirals
    ❌ Not available
    Immunoglobulin
    ❌ No fetal protection
    Vaccination in pregnancy
    ❌ Contraindicated
    Ignoring gestational age
    ❌ Major exam error

    TABLE 10: SUPER-HIGH-YIELD EXAM SNAPSHOT

    Heading
    One-Line Answer
    Virus
    Enveloped +ssRNA Togavirus
    Maternal illness
    Mild
    Fetal danger
    Severe CRS
    Worst timing
    1st trimester
    Diagnosis
    IgM = acute, IgG = immunity
    <12 weeks
    Offer termination
    Prevention
    MMR before pregnancy